IncFact
Company Profiles: Revenue, Growth, Competition

Corerx Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Corerx

Access the complete profile.

Corerx Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325412 Pharmaceutical Preparation Manufacturing
Address14205 Myerlake Circle
Clearwater, FL 33760

Note: Revenues for privately held companies are statistical evaluations.


Corerx's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Corerx is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Corerx Annual Revenue and Growth Rate

Corerx Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Corerx's revenues are gauged from an analysis of company filings.



Corerx's Income Statement (based on Industry Averages)

Corerx P&L$ Millions
Revenue (Sales) Corerx Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Corerx has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
March 25, 2019 0 100%$3 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Corerx is developing and marketing. Corerx's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
CORE BI SOLUTIONS
Lead generation services
08/17/2023
CORE RX
PHARMACEUTICAL DRUG DEVELOPMENT SERVICES
08/08/2019
DEVELOPMENT AT OUR CORE
PHARMACEUTICAL DRUG DEVELOPMENT SERVICES
08/08/2019

See all trademarks and details in the Full Report.


Market Share of Corerx's Largest Competitors

A competitive analysis shows these companies are in the same general field as Corerx, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIESColumbia, MD100 
SYNTRON BIORESEARCHCarlsbad, CA55 
RLS USALake Zurich, IL49 
ALORA PHARMACEUTICALSAlpharetta, GA42 
LANTHEUS HOLDINGSNorth Billerica, MA33 
BROADVIEW INVESTMENTSRoyston, GA32 
RESULTS RNAOrem, UT29 
CIVICALehi, UT28 
HARMONY BIOSCIENCESPlymouth Meeting, PA24 




Nearby Competitors

These companies are similar in business line and location to Corerx. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
CORERXClearwater, FL100 
BELCHER PHARMACEUTICALS LLC.Largo, FL87 
ION LABSLargo, FL77 
BIODERMLargo, FL74 
GROVEClearwater, FL52 
EMES2 PHARMACEUTICALSClearwater, FL6 




Future Competition: Corerx's Fastest Growing Competitors

These companies are in the same general field as Corerx and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Corerx Competitors